Pregnant women with systemic lupus erythematosus (SLE) who experience cardiovascular events are at high risk for adverse outcomes.

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL.

The average number of industry-funded oncology trials started per month fell 23.8%. Researchers have observed a decline in industry-sponsored post-approval clinical trials since the Inflation ...

Former President Joe Biden revealed that he has been diagnosed with prostate cancer on Friday. Biden, age 82 years, complained of urinary symptoms, which his doctors determined to be a prostate ...

Compared with nonuse, GLP-1RA and thiazolidinedione combination therapy reduced risks for all-cause and cardiovascular mortality in type 2 diabetes. The combination of a glucagon-like peptide 1 ...

Surgery patients staged with PSMA-PET appear to have a lower risk of early BCR than those staged with conventional imaging. Early oncologic outcomes after radical prostatectomy (RP) for very high ...

Working with an incomplete team >25 percent of the time linked to odds of burnout, intent to reduce hours, intent to leave. (HealthDay News) — Working with an incompletely staffed team is ...

Findings for matched groups of patients with obesity and diabetes taking first-generation GLP-1 RA or undergoing bariatric metabolic surgery. (HealthDay News) — Glucagon-like peptide-1 receptor ...

However, increased risk of self-harm is seen before initiation of treatment, during initial phase of treatment, and after discontinuation. (HealthDay News) — Gabapentinoids are not associated ...

Mortality difference amplified for users of medications for cardiovascular disease, chronic lung disease, HIV. (HealthDay News) — Loss of the Low-Income Subsidy (LIS) for drugs after Medicaid ...

Reducing PSA-based screening appears to have contributed to delayed detection and management of aggressive prostate cancer. While intended to reduce prostate cancer overdiagnosis and overtreatment ...

In an acute palliative care setting, intensive and comprehensive opioid management was effective for pain control without increasing doses among patients with advanced cancer. Individualized ...